SNAREopathies: Diversity in Mechanisms and Symptoms.
epilepsy
exocytosis
intellectual disability
membrane fusion
synapse
Journal
Neuron
ISSN: 1097-4199
Titre abrégé: Neuron
Pays: United States
ID NLM: 8809320
Informations de publication
Date de publication:
08 07 2020
08 07 2020
Historique:
received:
05
03
2020
revised:
29
04
2020
accepted:
26
05
2020
pubmed:
20
6
2020
medline:
9
10
2020
entrez:
20
6
2020
Statut:
ppublish
Résumé
Neuronal SNAREs and their key regulators together drive synaptic vesicle exocytosis and synaptic transmission as a single integrated membrane fusion machine. Human pathogenic mutations have now been reported for all eight core components, but patients are diagnosed with very different neurodevelopmental syndromes. We propose to unify these syndromes, based on etiology and mechanism, as "SNAREopathies." Here, we review the strikingly diverse clinical phenomenology and disease severity and the also remarkably diverse genetic mechanisms. We argue that disease severity generally scales with functional redundancy and, conversely, that the large effect of mutations in some SNARE genes is the price paid for extensive integration and exceptional specialization. Finally, we discuss how subtle differences in components being rate limiting in different types of neurons helps to explain the main symptoms.
Identifiants
pubmed: 32559416
pii: S0896-6273(20)30405-0
doi: 10.1016/j.neuron.2020.05.036
pii:
doi:
Substances chimiques
SNARE Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
22-37Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Interests M.V. participates in a holding that owns shares of Sylics (Synaptologics BV), a private company that offers STXBP1 and SNAP25 disease modeling, and has received consulting fees from Sylics.